Ϫ/Ϫ significant abnormalities in both thymic cellularity background, a mutant of SLP-76 that cannot be tyrosine (average ϭ 27.2 ϫ 10 6 thymocytes Ϯ 13.2 ϫ 10 6 , n ϭ phosphorylated (Y3F) fails to yield normal thymopoiesis, 8) and in maturation (4%-5% DN cells), yet to a lesser revealing defects both in the DN-to-DP transition and degree than that observed in Y3F-expressing mice. Alin selection. A second mutant of SLP-76 (⌬224-244), though the tyrosine residues and the Gads binding dowhich cannot interact with Gads, demonstrates inmain of SLP-76 appear to play critical roles in thymocreased activity compared to the Y3F mutant but reveals poiesis, expression of the SLP-76 R448K mutant is a role for this region in mediating optimal SLP-76 funcsufficient to reconstitute nearly normal thymic cellularity tion in thymopoiesis and T cell function. Interestingly, (average ϭ 83 ϫ 10 6 Ϯ 3 ϫ 10 6 , n ϭ 4) and CD4/CD8 mice expressing a mutation of SLP-76 in its SH2 domain surface profiles similar to those observed in SLP-76 ϩ/Ϫ exhibit nearly normal thymocyte development while dislittermate or transgenic SLP-76 WT-expressing mice, playing significant defects in mature T cell function. Colindicating that thymopoiesis can occur independently lectively, these data establish that there is a differential of the SLP-76 SH2 domain. Failure to reconstitute thyrequirement for SLP-76 domains in the regulation of mocyte development in Y3F-and ⌬224-244-expressing T cell development and function. ing the strength and duration of signaling, thereby reguFor stimulations, 24-well plates were coated overnight in the presence lating distinct outcomes. of 0.3 ml of a 10 ug/ml solution of purified anti-TCR␤ (H57-597). Cells were added at a density of 2 ϫ 10 6 per well in a total of 0.5 ml culture medium (RPMI, 10% FCS, l-glutamine, nonessential amino Experimental Procedures acids, sodium pyruvate, penicillin, streptomycin, and 5 ϫ 10 Ϫ5 M 2-mercaptoethanol), then cultured for 16-20 hr prior to analysis by Generation of SLP-76 Transgenic Mice flow cytometry. Wild-type murine SLP-76 cDNA was obtained from murine splenic RNA by RT-PCR. The SLP-76 Y3F and R448K mutant cDNAs were generated by overlap extension, using primers that created either TCR Clustering Assays Purified T cells were settled onto glass coverslips for 30 min followed phenylalanine substitutions at amino acid residues Y112, Y128, and Y145 for the Y3F mutation or a lysine substitution at amino acid residue by staining with 1 g/ml anti-CD3⑀ (2C11, Pharmingen, La Jolla, CA) at 37ЊC in staining buffer (PBS, 1% BSA, 1% goat serum) for 30 min. R448 for the R448K mutation. The SLP-76 ⌬224-244 mutant was generated by creating HindIII sites flanking amino acid residues 224-244 Cells were then washed in PBS and stimulated with 1 g/ml biotinylated goat anti-hamster antibody (Jackson ImmunoResearch, West followed by a three-way ligation. Sequence fidelity of all cDNAs was confirmed prior to subcloning into the EcoR1 and SalI sites of the Grove, PA) for 20 min at 37ЊC. Stimulations were stopped by fixation in 3.7% formaldehyde. Cells were then stained with FITC-streptavidin CD2 promoter/enhancer provided by Dr. P. Love (National Institutes of Health, Bethesda, MD). Transgenic mice were generated by miprior to analysis using a Nikon Eclipse E800 fluorescent microscope.
